Aug 16, 2024, 20:05
Focused ultrasound and cancer immunotherapy to develop safer and more efficient combination therapies – Cancer Research Institute
Cancer Research Institute shared a post on LinkedIn:
“Focused ultrasound and cancer immunotherapy are leading the charge to develop safer and more efficient combination therapies.
These cutting-edge technologies are proving to be pivotal, and are offering new hope for improved outcomes for patients.
Recently, CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, joined Focused Ultrasound Foundation’s podcast, Curing with Sound, to explore the future of cancer immunotherapy and its integration with focused ultrasound. Discover“
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18